申请人:MAO Hua
公开号:US20120283198A1
公开(公告)日:2012-11-08
A halogenated dideoxy sugar derivative, having the following general structure I wherein X is halogen,
R
1
and R
2
are H or Br; R
3
and R
4
are OH or OAc. The compounds 1-14 of the current invention has strong inhibition effect on human nasopharyngeal cancer CNE-2Z cells, human lung cancer A549 cells. human colon cancer HT-29 cells, human liver cancer Bel-7402 cells, human rectum cancer cells HCE 8693, human stomach cancer BGC-803 cells, human esophagus cancer CaEs-17 cells, human breast cancer cells MCF-7, human ovarian cancer cells A2780, pancreatic cancer cells PC-3, human bladder cells EJ, human brain glia cells TG-905, human leukemia cells K562, human melanoma M 14 cells and human anaplastic thyroid carcinoma TA-K cells. They can be used to prepare anti-tumor medicament and have significant clinic value.
一种卤代二脱氧糖衍生物,具有以下一般结构I,其中X为卤素,R1和R2为H或Br;R3和R4为OH或OAc。本发明的化合物1-14对人鼻咽癌CNE-2Z细胞、人肺癌A549细胞、人结肠癌HT-29细胞、人肝癌Bel-7402细胞、人直肠癌细胞HCE 8693、人胃癌BGC-803细胞、人食管癌CaEs-17细胞、人乳腺癌细胞MCF-7、人卵巢癌细胞A2780、胰腺癌细胞PC-3、人膀胱细胞EJ、人脑胶质细胞TG-905、人白血病细胞K562、人黑色素瘤M 14细胞和人间变性甲状腺癌TA-K细胞具有强烈的抑制作用。它们可以用于制备抗肿瘤药物,并具有显著的临床价值。